Brain volume and survival from age 78 to 85: The contribution of alzheimer-type magnetic resonance imaging findings

Journal of the American Geriatrics Society

Volumn 58, Issue 4, 2010, Pages 688-695

  Staff, Roger T ^a   Murray, Alison D ^d   Ahearn, Trevor ^b   Salarirad, Sima ^c   Mowat, Donald ^e   Starr, John M ^f,g   Deary, Ian J ^f   Lemmon, Helen ^e   Whalley, Lawrence J ^d  

^a Departments of Nuclear Medicine   (United States)

^b Departments of Magnetic Resonance Imaging   (United States)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e ROYAL CORNHILL HOSPITAL   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Dementia; Risk factors; Structural MRI; Survival

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PARIETAL LOBE; PREDICTION; SMOKING; SURVIVAL RATE; TEMPORAL LOBE; WHITE MATTER;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; CHI-SQUARE DISTRIBUTION; CLUSTER ANALYSIS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; LIFE EXPECTANCY; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SCOTLAND; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 77950430998     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02765.x     Document Type: Article

References (31)

1. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: Current concepts, and estimates from the Framingham study. Lancet Neurol 2007 6:1106 1114. (Pubitemid 350123607)
2. Goldacre MJ, Duncan ME, Griffith M et al. Psychiatric disorders certified on death certificates in an English population. Soc Psychiatry Psychiatr Epidemiol 2006 41:409 414. (Pubitemid 43676257)
3. Ridha BH, Barnes J, Bartlett JW et al. Tracking atrophy progression in familial Alzheimer's Disease: A serial MRI study. Lancet Neurol 2006 5:828 834. (Pubitemid 44715810)
4. MacLullich AMJ, Ferguson KJ, Deary IJ et al. Intracranial capacity and brain volumes are associated with cognition in healthy elderly men. Neurology 2002 59:169 174.
5. Whalley LJ, Deary IJ. Longitudinal cohort study of childhood IQ and survival up to age 76. Br Med J 2001 322:819 822. (Pubitemid 32291129)
6. Ebikryston KL. Respiratory symptoms and pulmonary-function as predictors of 10-year mortality from respiratory-disease, cardiovascular-disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988 41:251 260.
7. Ostbye T, Krause KM, Norton MC et al. Ten dimensions of health and their relationships with overall self-reported health and survival in a predominately religiously active elderly population: The Cache County Memory Study. J Am Geriatr Soc 2006 54:199 209.
8. Scottish Council for Research in Education. The Intelligence of Scottish School Children: A National Survey of an Age Group.
9. Deary IJ, Whiteman MC, Starr JM et al. The impact of childhood intelligence on later life: Following up the Scottish Mental Surveys of 1932 and 1947. J Pers Soc Psychol 2004 86:130 147.
10. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000 11:805 821. (Pubitemid 30437668)
11. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imag 1998 17:87 97.
12. Rudick RA, Fisher E, Lee JC et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 1999 53:1698 1704. (Pubitemid 29530342)
13. Good CD, Johnsrude IS, Ashburner J et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001 14:21 36.
14. Fazekas F, Kleinert R, Offenbacher H et al. Pathological correlates of incidental MRI white-matter signal hyperintensities. Neurology 1993 43:1683 1689.
15. Raven JC. Guide to the Progressive Matrices.
16. Query WT, Megran J. Age-related norms for AVLT in a male patient population. J Clin Psychol 1983 39:136 138.
17. Murray AD, Staff RT, Shenkin SD et al. Brain white matter hyperintensities: Relative importance of vascular risk factors in nondemented elderly people. Radiology 2005 237:251 257.
18. MacLeod MJ, De Lange RP, Breen G et al. Lack of association between apolipoprotein E genotype and ischaemic stroke in a Scottish population. Eur J Clin Invest 2001 31:570 573.
19. World Health Organization. International Classification of Disease (ICD) 311. 1992.
20. Kuller LH, Arnold AM, Longstreth WT Jr. et al. White matter grade and ventricular volume on brain MRI as markers of longevity in the Cardiovascular Health Study. Neurobiol Aging 2007 28:1307 1315.
21. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991 82:239 259.
22. Scheltens P. Neuroimaging in dementia: Beyond exclusion. Neurobiol Aging 2002 23:2059.
23. Convit A, DeLeon MJ, Tarshish C et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 1997 18:131 138.
24. Reiman EM, Uecker A, Caselli RJ et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998 44:288 291.
25. Morris JC. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics 2005 Suppl:9 14.
26. Brookmeyer R, Corrada MM, Curriero FC et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002 59:1764 1767.
27. Hui JS, Wilson RS, Bennett DA et al. Rate of cognitive decline and mortality in Alzheimer's disease. Neurology 2003 61:1356 1361.
28. Larson EB, Shadlen MF, Wang L et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004 140:501 509.
29. Ganguli M, Dodge HH, Shen CY et al. Alzheimer disease and mortality - a 15-year epidemiological study. Arch Neurol 2005 62:779 784. (Pubitemid 40656094)
30. Wolfson C, Wolfson DB, Asgharian M et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001 344:1111 1116. (Pubitemid 32285231)
31. Hole DJ, Watt GCM, DaveySmith G et al. Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley Prospective Population Study. BMJ 1996 313:711 715.